Return On Equity of Prelude Therapeutics Inc from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Prelude Therapeutics Inc quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Prelude Therapeutics Inc Return On Equity for the quarter ending 30 Sep 2025 was -121%, a 81% decline year-over-year.
  • Prelude Therapeutics Inc annual Return On Equity for 2024 was -75%, a 40% decline from 2023.
  • Prelude Therapeutics Inc annual Return On Equity for 2023 was -53%, a 5.9% decline from 2022.
  • Prelude Therapeutics Inc annual Return On Equity for 2022 was -50%, a 45% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Prelude Therapeutics Inc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -121% -54% -81% 01 Jul 2025 30 Sep 2025
Q2 2025 -107% -47% -78% 01 Apr 2025 30 Jun 2025
Q1 2025 -89% -36% -68% 01 Jan 2025 31 Mar 2025
Q4 2024 -75% -21% -40% 01 Oct 2024 31 Dec 2024
Q3 2024 -67% -13% -24% 01 Jul 2024 30 Sep 2024
Q2 2024 -60% -5% -8.9% 01 Apr 2024 30 Jun 2024
Q1 2024 -53% +2% +3.4% 01 Jan 2024 31 Mar 2024
Q4 2023 -53% -3% -5.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -54% -6% -13% 01 Jul 2023 30 Sep 2023
Q2 2023 -55% -11% -25% 01 Apr 2023 30 Jun 2023
Q1 2023 -55% -15% -37% 01 Jan 2023 31 Mar 2023
Q4 2022 -50% -16% -45% 01 Oct 2022 31 Dec 2022
Q3 2022 -48% -15% -47% 01 Jul 2022 30 Sep 2022
Q2 2022 -44% -14% -47% 01 Apr 2022 30 Jun 2022
Q1 2022 -40% -2% -6.4% 01 Jan 2022 31 Mar 2022
Q4 2021 -35% +38% +52% 01 Oct 2021 31 Dec 2021
Q3 2021 -32% +342% +91% 01 Jul 2021 30 Sep 2021
Q2 2021 -30% -99% -143% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% -108% -154% 01 Jan 2021 31 Mar 2021
Q4 2020 -73% -146% -199% 01 Oct 2020 31 Dec 2020
Q3 2020 -374% 01 Jul 2020 30 Sep 2020
Q2 2020 69% 01 Apr 2020 30 Jun 2020
Q1 2020 70% 01 Jan 2020 31 Mar 2020
Q4 2019 73% 01 Oct 2019 31 Dec 2019

Prelude Therapeutics Inc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -75% -21% -40% 01 Jan 2024 31 Dec 2024
2023 -53% -3% -5.9% 01 Jan 2023 31 Dec 2023
2022 -50% -16% -45% 01 Jan 2022 31 Dec 2022
2021 -35% +38% +52% 01 Jan 2021 31 Dec 2021
2020 -73% -146% -199% 01 Jan 2020 31 Dec 2020
2019 73% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.